Related references
Note: Only part of the references are listed.Weighing the role of skeletal muscle mass and muscle density in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: a multicenter real-life study
Alessio Cortellini et al.
SCIENTIFIC REPORTS (2020)
I-SABR phase II randomized study of nivolumab immunotherapy and stereotactic ablative radiotherapy in early stage NSCLC: Interim analysis adverse effects.
Joe Y. Chang et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial
David Ball et al.
LANCET ONCOLOGY (2019)
Impact of early inflammatory cytokine elevation after commencement of PD-1 inhibitors to predict efficacy in patients with non-small cell lung cancer
Yuichi Ozawa et al.
MEDICAL ONCOLOGY (2019)
Treatment strategy and decision-making for elderly surgical candidates with early lung cancer
Jiro Okami
JOURNAL OF THORACIC DISEASE (2019)
Association of Sarcopenia with and Efficacy of Anti-PD-1/PD-L1 Therapy in Non-Small-Cell Lung Cancer
Naoya Nishioka et al.
JOURNAL OF CLINICAL MEDICINE (2019)
The Relationship between Imaging-Based Body Composition Analysis and the Systemic Inflammatory Response in Patients with Cancer: A Systematic Review
Tanvir Abbass et al.
CANCERS (2019)
Combining stereotactic body radiation therapy with immunotherapy: current data and future directions
Alexander J. Lin et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2019)
Prevalence and predictive value of pre-therapeutic sarcopenia in cancer patients: A systematic review
Frederic Pamoukdjian et al.
CLINICAL NUTRITION (2018)
Changes in treatment patterns and survival in elderly patients with stage I non-small-cell lung cancer with the introduction of stereotactic body radiotherapy and video-assisted thoracic surgery
Deniece D. E. M. A. Detillon et al.
EUROPEAN JOURNAL OF CANCER (2018)
Chapter 1 Definitions and diagnosis of sarcopenia
Masahiro Akishita et al.
GERIATRICS & GERONTOLOGY INTERNATIONAL (2018)
Chapter 2 Epidemiology of sarcopenia
Hiroshi Shimokata et al.
GERIATRICS & GERONTOLOGY INTERNATIONAL (2018)
Impact of low skeletal muscle mass on non-lung cancer mortality after stereotactic body radiotherapy for patients with stage I non-small cell lung cancer
Yukinori Matsuo et al.
JOURNAL OF GERIATRIC ONCOLOGY (2018)
Systemic Inflammation Biomarkers Predict Survival in Patients of Early Stage Non-Small Cell Lung Cancer Treated With Stereotactic Ablative Radiotherapy - A Single Center Experience
Hui Luo et al.
JOURNAL OF CANCER (2018)
Combination of CRP and NLR: a better predictor of postoperative survival in patients with gastric cancer
Jing Guo et al.
CANCER MANAGEMENT AND RESEARCH (2018)
Long-term Results of Stereotactic Body Radiation Therapy in Medically Inoperable Stage I Non-Small Cell Lung Cancer
Robert D. Timmerman et al.
JAMA ONCOLOGY (2018)
Pretreatment Immune Parameters Predict for Overall Survival and Toxicity in Early-Stage Non-Small-Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy
Narek Shaverdian et al.
CLINICAL LUNG CANCER (2016)
Prognostic value of pretreatment circulating neutrophils, monocytes, and lymphocytes on outcomes in lung stereotactic body radiotherapy
M. Giuliani et al.
CURRENT ONCOLOGY (2016)
Prognostic value of sarcopenia in adults with solid tumours: A meta-analysis and systematic review
Shlomit Strulov Shachar et al.
EUROPEAN JOURNAL OF CANCER (2016)
Baseline C-reactive protein level predicts survival of early-stage lung cancer: evidence from a systematic review and meta-analysis
Giovanni Leuzzi et al.
TUMORI JOURNAL (2016)
Baseline C-reactive protein level predicts survival of early-stage lung cancer: evidence from a systematic review and meta-analysis
Giovanni Leuzzi et al.
TUMORI JOURNAL (2016)
Long-term results of a prospective phase II trial of medically inoperable stage I NSCLC treated with SBRT - the Nordic experience
Karin Lindberg et al.
ACTA ONCOLOGICA (2015)
Sarcopenia: Current Concepts and Imaging Implications
Robert D. Boutin et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2015)
Pretreatment Modified Glasgow Prognostic Score Predicts Clinical Outcomes After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer
Takahiro Kishi et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
Prospective Trial of Stereotactic Body Radiation Therapy for Both Operable and Inoperable T1N0M0 Non-Small Cell Lung Cancer: Japan Clinical Oncology Group Study JCOG0403
Yasushi Nagata et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
The Impact of Sarcopenia on Survival and Complications in Surgical Oncology: A Review of the Current Literature
Savita Joglekar et al.
JOURNAL OF SURGICAL ONCOLOGY (2015)
Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios as Prognostic Factors after Stereotactic Radiation Therapy for Early-Stage Non-Small-Cell Lung Cancer
Nathan A. Cannon et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
Prognostic value of neutrophil-lymphocyte ratio and level of C-reactive protein in a large cohort of pancreatic cancer patients: a retrospective study in a single institute in Japan
Dai Inoue et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2015)
C-Reactive Protein Is an Important Biomarker for Prognosis Tumor Recurrence and Treatment Response in Adult Solid Tumors: A Systematic Review
Shiva Shrotriya et al.
PLOS ONE (2015)
Paraspinous muscle as a predictor of surgical outcome
Leah D. Canvasser et al.
JOURNAL OF SURGICAL RESEARCH (2014)
Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
Arnoud J. Templeton et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Cancer-related inflammation and treatment effectiveness
Connie I. Diakos et al.
LANCET ONCOLOGY (2014)
Inflammatory markers in population studies of aging
Tushar Singh et al.
AGEING RESEARCH REVIEWS (2011)
Consequences of Sarcopenia
Marjolein Visser et al.
CLINICS IN GERIATRIC MEDICINE (2011)